07.25.23
In our July 18, 2023, webinar titled “False Claims Act 2023: What Every Health Care Entity Working with the Government Needs to Know,” Manatt posed the following hypothetical and asked three questions about it in our live poll.
07.24.23
On July 13, the Centers for Medicare & Medicaid Services released its annual proposed rule updating the Medicare Physician Fee Schedule for calendar year 2024.
07.21.23
On July 20, 2023, the OCR at the HHS and the FTC sent a joint letter to approximately 130 hospital systems and telehealth providers to alert them to the “serious privacy and security risks” stemming from the use of online tracking technologies integrated into their websites and mobile ...
07.18.23
After a COVID-19-related delay, on June 27, the Department of Health and Human Services Office of Inspector General released a long-awaited final rule that establishes monetary penalties for violations of health information technology information blocking rules.
07.13.23
In a webinar titled Strategies for Providing Whole Child Care: A Blueprint for Meeting Children’s Social Needs, Manatt facilitated a panel discussion with state and national leaders who are pioneering new ways to address the health-related social needs (HRSNs) of children, which the Centers ...
07.12.23
A first-of-its-kind Florida law requires health care providers to keep certain patient data within the United States, its territories or Canada.
07.11.23
Mass General Hospital is one of the oldest and most prestigious hospitals in the United States.
07.10.23
On June 30, 2023, the Centers for Medicare & Medicaid Services (CMS) approved Washington’s five-year Section 1115 demonstration renewal, the Medicaid Transformation Project 2.0 (MTP 2.0 or Demonstration).
07.05.23
After around-the-clock weekend negotiations between Democratic legislative leaders and Governor Newsom, working against a looming June 30 constitutional deadline, leaders announced a budget agreement late Monday night.
06.28.23
On June 23, 2023, FDA issued a first-of-its-kind draft guidance for sponsors of studies of psychedelic drugs. The guidance arrived just as the Psychedelic Science 2023 conference in Denver was wrapping up.